Aurinia Pharmaceuticals (AUPH) Gross Profit (QoQ) (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) Gross Profit (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Aurinia Pharmaceuticals | 2.07 Bn | 1.69 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.22% |
| Dec 31, 2025 | 4.63% |
| Sep 30, 2025 | 3.81% |
| Jun 30, 2025 | 16.70% |
| Mar 31, 2025 | -0.78% |
| Dec 31, 2024 | -12.02% |
| Sep 30, 2024 | 27.86% |
| Jun 30, 2024 | 13.47% |
| Mar 31, 2024 | 7.18% |
| Dec 31, 2023 | -16.85% |
| Sep 30, 2023 | 19.57% |
| Jun 30, 2023 | 17.49% |
| Mar 31, 2023 | 25.54% |
| Dec 31, 2022 | -49.24% |
| Sep 30, 2022 | 100.56% |
| Jun 30, 2022 | 24.44% |
| Mar 31, 2022 | -6.78% |
| Dec 31, 2021 | 59.04% |
| Sep 30, 2021 | 128.34% |
| Jun 30, 2021 | 628.87% |